STEROIDS REPRESS LH THROUGH PROTEIN/PROTEIN INTERACTIONS
类固醇通过蛋白质/蛋白质相互作用抑制 LH
基本信息
- 批准号:6498097
- 负责人:
- 金额:$ 4.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2002-04-30
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein androgen receptor estrogen receptors genetic library genetic regulation genetically modified animals hormone regulation /control mechanism laboratory mouse luteinizing hormone phosphorylation protein protein interaction receptor expression steroid hormone receptor transfection yeast two hybrid system
项目摘要
My immediate goal is to develop an equal background in research to what
I had already devoted to clinical work. Therefore, I decided to pursue
a doctoral degree with Dr. John Nilson at Case Western Reserve
University (CWRU). My long term career goals are to combine my talents
in basic science and clinical medicine in a faculty position at a
veterinary teaching institution. The program in Dr. Nilson's laboratory
and the environment at CWRU provide extraordinary access to any required
resources. My research career development will be nurtured in this
environment with the access to numerous structured meetings and training
opportunities. Here I will learn how to critically evaluate data which
will allow me to plan logical new experiments. In addition, I will
receive invaluable training in writing succinct and meaningful
scientific research papers and grant proposals. These achievements are
critical in striving for my ultimate goal of becoming an independent
researcher.
This grant addresses the overall working hypothesis that the androgen
and estrogen receptors repress lutropin expression through multiple
protein-protein interactions in gonadotropes. Evidence indicates that
AR in gonadotropes suppresses the alpha subunit promoter through
protein-protein interactions that involve two distinct regulatory
elements. However the identity of these critical proteins remains
unknown. In Aim 1, the yeast two-hybrid approach will be used in both
a directed and random fashion to screen for co-repressor proteins. In
addition, we postulate that at least one phosphorylated residue of the
AR is required for successful interaction with the co-repressor protein.
We intend to test this hypothesis in Aim 2 by transiently transfecting
AR phosphorylation mutants with the alpha subunit promoter in
gonadotrope cells. Finally, we plan to exploit the knowledge gained on
the alpha subunit suppression mechanism to enable us to unlock the
mystery behind LHbeta regulation. In Aim 3, we propose to design
transgenic mice in order to define the site and mechanism of
steroidogenic regulation on the LHbeta subunit gene.
我的直接目标是在研究方面建立一个与
我已经投入到临床工作中了。因此,我决定继续
凯斯西储大学约翰·尼尔森博士的博士学位
大学(CWRU)。我的长期职业目标是把我的才能结合起来
在基础科学和临床医学方面担任教职
兽医教学机构。尼尔森博士实验室里的程序
CWRU的环境提供了非凡的访问权限
资源。我的研究生涯将在这里得到培育
能够参加大量有组织的会议和培训的环境
机遇。在这里,我将学习如何批判性地评估数据
会让我计划合乎逻辑的新实验。另外,我会
接受无价之宝的写作训练,简洁而有意义
科研论文和资助建议。这些成就是
在为我成为一个独立的人的最终目标而奋斗时至关重要
研究员。
这项拨款解决了总体上的工作假设,即雄激素
雌激素受体通过多种途径抑制促黄体生成素的表达
促性腺激素中的蛋白质-蛋白质相互作用。有证据表明,
促性腺激素受体通过抑制α亚基启动子
蛋白质-蛋白质相互作用涉及两种不同的调节
元素。然而,这些关键蛋白质的特性仍然存在
未知。在目标1中,酵母双杂交方法将在这两种方法中使用
一种定向和随机的方式来筛选共抑制蛋白。在……里面
此外,我们假设至少有一个磷酸化残基
AR是与共抑制蛋白成功相互作用所必需的。
我们打算通过瞬时转染法在目标2中验证这一假设。
含α亚基启动子的AR磷酸化突变体
促性腺激素细胞。最后,我们计划利用从
阿尔法亚单位抑制机制使我们能够解锁
LHbeta调控背后的奥秘。在目标3中,我们建议设计
转基因小鼠,以确定其作用部位和机制
LHbeta亚基基因的类固醇合成调控。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan S Jorgensen其他文献
Joan S Jorgensen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan S Jorgensen', 18)}}的其他基金
University of Wisconsin-Madison Postbaccalaureate Research Education Program (PREP) for increasing diversity in STEM
威斯康星大学麦迪逊分校学士后研究教育计划 (PREP),旨在增加 STEM 的多样性
- 批准号:
10706455 - 财政年份:2022
- 资助金额:
$ 4.07万 - 项目类别:
Sexually Dimorphic Regulation Of SF-1 In Gonadogenesis
SF-1 在性腺发生中的性二态性调节
- 批准号:
7000316 - 财政年份:2005
- 资助金额:
$ 4.07万 - 项目类别:
Sexually Dimorphic Regulation Of SF-1 In Gonadogenesis
SF-1 在性腺发生中的性二态性调节
- 批准号:
6861432 - 财政年份:2005
- 资助金额:
$ 4.07万 - 项目类别:
STEROIDS REPRESS LH THROUGH PROTEIN/PROTEIN INTERACTIONS
类固醇通过蛋白质/蛋白质相互作用抑制 LH
- 批准号:
6628529 - 财政年份:1999
- 资助金额:
$ 4.07万 - 项目类别:
STEROIDS REPRESS LH THROUGH PROTEIN/PROTEIN INTERACTIONS
类固醇通过蛋白质/蛋白质相互作用抑制 LH
- 批准号:
6350627 - 财政年份:1999
- 资助金额:
$ 4.07万 - 项目类别:
STEROIDS REPRESS LH THROUGH PROTEIN/PROTEIN INTERACTIONS
类固醇通过蛋白质/蛋白质相互作用抑制 LH
- 批准号:
6749325 - 财政年份:1999
- 资助金额:
$ 4.07万 - 项目类别:
STEROIDS REPRESS LH THROUGH PROTEIN/PROTEIN INTERACTIONS
类固醇通过蛋白质/蛋白质相互作用抑制 LH
- 批准号:
2724772 - 财政年份:1999
- 资助金额:
$ 4.07万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 4.07万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 4.07万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 4.07万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 4.07万 - 项目类别:














{{item.name}}会员




